Black Rock Inc. Passage Bio, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Passage Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 817,529 shares of PASG stock, worth $425,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares

817,529

Previous 922,547 11.38%

Holding current value

$425,115

Previous $1.25 Million 48.19%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.79 - $1.58 $82,964 - $165,928	-105,018 Reduced 11.38%	817,529 $645,000
Q1 2024 May 10, 2024	SELL	$0.86 - $1.73 $86,013 - $173,027	-100,016 Reduced 9.78%	922,547 $1.25 Million
Q4 2023 Feb 13, 2024	BUY	$0.6 - $1.01 $6,143 - $10,341	10,239 Added 1.01%	1,022,563 $1.03 Million
Q3 2023 Nov 13, 2023	SELL	$0.66 - $1.01 $28,312 - $43,326	-42,898 Reduced 4.07%	1,012,324 $668,000
Q2 2023 Aug 11, 2023	BUY	$0.82 - $1.19 $1,002 - $1,455	1,223 Added 0.12%	1,055,222 $991,000
Q1 2023 May 12, 2023	SELL	$0.96 - $1.88 $66,910 - $131,032	-69,698 Reduced 6.2%	1,053,999 $1.01 Million
Q4 2022 Feb 13, 2023	SELL	$1.06 - $1.48 $233,459 - $325,962	-220,245 Reduced 16.39%	1,123,697 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$1.22 - $2.48 $29,774 - $60,524	-24,405 Reduced 1.78%	1,343,942 $1.68 Million
Q2 2022 Aug 12, 2022	SELL	$1.63 - $3.46 $3.14 Million - $6.66 Million	-1,924,445 Reduced 58.44%	1,368,347 $3.23 Million
Q1 2022 May 12, 2022	SELL	$2.66 - $6.49 $528,709 - $1.29 Million	-198,763 Reduced 5.69%	3,292,792 $10.2 Million
Q4 2021 Feb 10, 2022	BUY	$6.24 - $10.2 $2.33 Million - $3.81 Million	373,532 Added 11.98%	3,491,555 $22.2 Million
Q3 2021 Nov 09, 2021	BUY	$9.73 - $15.52 $163,152 - $260,239	16,768 Added 0.54%	3,118,023 $31.1 Million
Q2 2021 Aug 11, 2021	BUY	$12.44 - $19.45 $38.6 Million - $60.3 Million	3,101,255 New	3,101,255 $41.1 Million

Others Institutions Holding PASG

# of Institutions

Shares Held

38.7M

Call Options Held

7.7K

Put Options Held

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $28.3M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account